Rob Gietl, MYM Nutraceuticals CEO focus on Cannabis Consumables Facility

Rob Gietl, CEO of MYM Nutraceuticals, focus cannabis company in the medical industry.

MYM is a integrated cannabis company with the prime directive of our business plan.
 
We were going off business models that we’ve seen in the U.S.
More important, we’re here for the long-term and more stability in that category.
 
One is the development of seed and live tissue culture. Furthersome which we can sell through a variety of different seed banks around the world.
 
And sell for ourselves through two things, first, one is to keep the quality of the product. And make sure that we do not have any gaps in our production schedule.
 
We also have many large grows in Canada and abroad. We produce flower for and we have the capability of doing extraction down to oil.
 
Also, have a manufacturing facility that’s on its final stages of completion right now. It allows us to produce final consumables in the forms of transdermal patches.
 
RND and various developments in countries are fascinating. They are growing on daily basis and medical responses.

About MYM Nutraceuticals

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end medicinal cannabis supplements and topical products.

The company also has interest in two international cannabis production projects in Australia and Colombia.

In New South Wales, Australia, the “Northern Rivers Project” have 1.2 million square feet of cannabis production space.

In Medellin, Colombia, MYM and Colombia Organica are planning to build a cannabis production facility in the region.

Furthersome, Colombia Organica is in the licensing process for the cultivation and production of high-THC cannabis extracts.

To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors.

MYM through its various joint ventures is currently building three large-scale production facilities in both Canada and Australia.

As a result, upon completion of these three projects, the total amount of greenhouse growing space is expected to exceed 2.7 million square feet.

For more information on MYM Nutraceuticals (MYM:CSE) please fill out the form below.

Request Investor Kit

Name*

Email*

*Required.